Regina Stark

11PUBLICATIONS
44CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 21, 2026
Lung tumouroids as a testing platform for precision CAR T cell therapy.

Lukas Ehlen, Martí Farrera-Sal, Martin Szyska

|May 21, 2025
CD8<sup>+</sup> T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells.

Phillip Schiele, Alberto Sada Japp, Regina Stark

|Apr 07, 2022
Hobit and Blimp-1 regulate T<sub>RM</sub> abundance after LCMV infection by suppressing tissue exit pathways of T<sub>RM</sub> precursors.

Loreto Parga-Vidal, Renske L R E Taggenbrock, Ammarina Beumer-Chuwonpad

|Jan 26, 2022
Tissue-resident memory T cells in the urogenital tract.

Loreto Parga-Vidal, Michiel C van Aalderen, Regina Stark

|Dec 13, 2021
Hobit and Blimp-1 instruct the differentiation of iNKT cells into resident-phenotype lymphocytes after lineage commitment.

Natasja Am Kragten, Renske Lre Taggenbrock, Loreto Parga Vidal

|Aug 21, 2021
Hobit identifies tissue-resident memory T cell precursors that are regulated by Eomes.

Loreto Parga-Vidal, Felix M Behr, Natasja A M Kragten

Pageof 2